SARGENT INVESTMENT GROUP, LLC – Spectrum Pharmaceuticals, Inc. Transaction History
SARGENT INVESTMENT GROUP, LLC portfolio value:
$252,000
portfolio value
SARGENT INVESTMENT GROUP, LLC quarter portfolio value change:
-44.87%
quarter
Spectrum Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -6.51% | -40K shares | -227K | $0.43 | 574.6K |
| Q2 2022 | share | Increase | +48.24% | 200K shares | -56K | $0.78 | 614.6K |
| Q1 2022 | share | Increase | +2739.73% | 400K shares | 516K | $1.29 | 414.6K |
| Q4 2021 | share | Decrease | -90.79% | -144K shares | -327K | $1.35 | 14.6K |
| Q3 2021 | share | Decrease | -3.43% | -5.62K shares | -270K | $2.18 | 158.6K |
| Q2 2021 | share | Increase | +4.25% | 6.7K shares | 102K | $3.75 | 164.22K |
| Q1 2021 | share | Decrease | -9.74% | -17K shares | -81K | $3.26 | 157.52K |
| Q4 2020 | share | Decrease | -29.61% | -73.42K shares | -417K | $3.41 | 174.52K |
| Q3 2020 | share | Increase | +60.64% | 93.6K shares | 448K | $4.08 | 247.94K |
| Q2 2020 | share | Decrease | -8.11% | -13.62K shares | 173K | $3.38 | 154.34K |
| Q1 2020 | share | Decrease | -6.72% | -12.1K shares | -264K | $2.33 | 167.97K |
| Q4 2019 | share | Decrease | -66.38% | -355.57K shares | -3.78M | $3.64 | 180.07K |
| Q3 2019 | share | Increase | +15.84% | 73.24K shares | 462K | $8.3 | 535.64K |
| Q2 2019 | share | Decrease | -1.28% | -6K shares | -1.02M | $8.61 | 462.40K |
| Q1 2019 | share | Increase | +4.56% | 20.41K shares | 1.08M | $10.69 | 468.40K |
| Q4 2018 | share | Increase | 0.00% | 447.99K shares | 3.92M | $8.75 | 447.99K |